Hongyan Zhu

Title: Innovations by Hongyan Zhu in Pharmaceutical Development

Introduction

Hongyan Zhu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug formulations. His work focuses on improving the properties of existing compounds to enhance their therapeutic efficacy.

Latest Patents

Hongyan Zhu holds a patent for the "Crystal form of lanifibranor, preparation method therefor, and use thereof." This patent introduces novel crystalline forms of Lanifibranor, referred to as 'Compound I.' The patent outlines preparation methods for these crystalline forms, pharmaceutical compositions containing them, and their uses in developing pan-PPAR agonist drugs and treatments for Non-Alcoholic Steatohepatitis (NASH). Compared to prior arts, the crystalline forms of Compound I exhibit one or more improved properties, addressing issues found in previous formulations and providing valuable insights for drug optimization and development.

Career Highlights

Hongyan Zhu is associated with Crystal Pharmaceutical (Suzhou) Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the company's research and development efforts, particularly in the area of drug formulation and optimization.

Collaborations

Hongyan Zhu collaborates with Minhua Chen, who is also a key figure in the research team. Their combined efforts contribute to the ongoing advancements in pharmaceutical sciences and the development of effective treatments.

Conclusion

Hongyan Zhu's innovative work in the field of pharmaceuticals, particularly through his patent on Lanifibranor, showcases his commitment to enhancing drug formulations. His contributions are significant in addressing medical challenges and improving patient outcomes.